Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Check which altcoins have active Github in 2024 to gauge real development engagement. Compare commit activity and contributor counts to identify strong projects.
26,463 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A surprise accounting disclosure sent Driven Brands shares skidding. This guide breaks down what happened, how to ass...
Apple launched the MacBook Neo at a budget price, signaling a potential breakthrough for Mac demand. This article bre...
When great news KLAC stock hits the headlines, investors want a clear game plan. This guide breaks down the potential...
Torn between buying Amazon or SpaceX stock? Learn how a broad AI and technology ETF that holds both could simplify yo...
Uniswap activated its fee switch today, enabling on-chain UNI buybacks funded by protocol fees. The move links revenu...
A tech giant stepping into real estate could change how buyers find listings and compare loans. This article explains...
In a choppy market, dividend stocks double right by combining reliable income with growth potential. This guide highl...
When a CEO buys a large block of shares, investors take notice. This article dives into what the purchase of 250,000 ...
As energy markets shift, a bold forecast asks whether Enbridge will look the same in 15 years. This analysis breaks d...
Oracle shares have fallen sharply as investors reassess AI-related capital expenditure. This piece compares Oracle’s ...
In February, Figma exhibited a notable stock move as investor interest focused on cloud-based collaboration tools. Th...